Showing 2,121 - 2,140 results of 4,618 for search 'significantly ((lower decrease) OR (linear decrease))', query time: 0.23s Refine Results
  1. 2121

    Row data. by Xiangyu Wang (341093)

    Published 2025
    “…<div><p>Objective</p><p>Body image perception significantly impacts university students’ well-being and potentially their creativity. …”
  2. 2122
  3. 2123

    Changes in the neutrophil count. by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  4. 2124

    Changes in the platelet count. by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  5. 2125

    Changes in the white blood cell count. by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  6. 2126

    Changes in the hemoglobin. by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  7. 2127

    WBC and ANC on day 7 post-chemotherapy. by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  8. 2128

    General clinical data of 88 patients with NPC. by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  9. 2129

    CONSORT participant flow diagram. by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  10. 2130

    S4 File - by Lu Yang (30847)

    Published 2025
    “…The rate of delayed chemotherapy in the experimental group was lower than that in the control group (2.3% vs. 29.5%), P = 0.001; the rate of interruption of radiotherapy in the experimental group was lower than that in the control group (2.3% vs.27.3%), P = 0.003; 4. …”
  11. 2131

    SPSS data. by Myriam El Khoury-Malhame (14185996)

    Published 2025
    “…</p><p>Conclusion</p><p>Stigma remains a pervasive condition closely related to increased psychological suffering, decreased self-esteem and lower tendencies to seek help. …”
  12. 2132

    Green Hydrogen Economy: Scenarios versus Technologies by Hua Fan (495346)

    Published 2025
    “…Historical trends in LCOH indicate that lower off-grid renewable electricity costs are pivotal in decreasing production expenses, whereas electrolysis efficiencies remain relatively constant. …”
  13. 2133

    Flowchart of the screening process. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  14. 2134

    Result of the AMSTAR-2 assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  15. 2135

    Characteristics of included reviews. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  16. 2136

    Result of the PRISMA assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  17. 2137

    Result of the ROBIS assessments. by Huixia Ren (500186)

    Published 2025
    “…Efficacy was assessed through intraoperative outcomes, primary postoperative outcomes, and statistically significant postoperative outcomes. Patients with thyroid disorders undergoing TOTVA experienced longer overall operative time and hospital stays, reduced intraoperative blood loss, increased lymph node retrieval, higher incidence of infection, lower postoperative pain scores, reduced incidence of hypocalcemia, larger drainage volumes, and higher cosmetic effect scores compared with those undergoing.…”
  18. 2138
  19. 2139
  20. 2140

    Benchmark regression results. by Pengyu Yang (2668450)

    Published 2024
    “…The findings reveal that: (1) At this stage, digital transformation in listed companies effectively reduces their carbon intensity, but the relationship between the two is not linear; instead, it exhibits a U-shaped trajectory, initially decreasing then increasing. (2) Analysis of mechanism indicates that costs associated with environmental governance and innovations in green technology serve as critical pathways through which corporate digital transformation influences carbon intensity. (3) The analysis of driving effect suggests that the digital transformation significantly curtails the carbon emission intensity of both upstream and downstream enterprises as well as those within the same industry and geographical region, through industrial linkage and the cohort effect. (4) Heterogeneity analysis elucidates that the digital transformation of enterprises in regions with stronger government environmental regulations has a markedly more pronounced effect on reducing the carbon emission intensity. …”